Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide and Pamidronate in Multiple Myeloma with Poor Hematopoietic Reserve
NCT00083408Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Mar 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in multiple myeloma (MM), sponsored by University of Arkansas. Started Mar 1998; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00083408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083408.